<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Anaesth</journal-id><journal-id journal-id-type="iso-abbrev">Br J Anaesth</journal-id><journal-id journal-id-type="publisher-id">bjaint</journal-id><journal-id journal-id-type="hwp">brjana</journal-id><journal-title-group><journal-title>BJA: British Journal of Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">0007-0912</issn><issn pub-type="epub">1471-6771</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24946778</article-id><article-id pub-id-type="pmc">4235570</article-id><article-id pub-id-type="doi">10.1093/bja/aeu157</article-id><article-id pub-id-type="publisher-id">aeu157</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group></article-categories><title-group><article-title>Managing malaria in the intensive care unit</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Marks</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Gupta-Wright</surname><given-names>A.</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Doherty</surname><given-names>J. F.</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Singer</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Walker</surname><given-names>D.</given-names></name><xref ref-type="aff" rid="af3">3</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff id="af1"><label>1</label><addr-line>The Hospital for Tropical Diseases</addr-line>, <institution>Mortimer Market Centre</institution>, <addr-line>Capper Street, London</addr-line>, <country>UK</country></aff><aff id="af2"><label>2</label><addr-line>Department of Clinical Research</addr-line>, <institution>Faculty of Infectious and Tropical Diseases London School of Hygiene and Tropical Medicine</institution>, <addr-line>Keppel Street, London</addr-line>, <country>UK</country></aff><aff id="af3"><label>3</label><addr-line>Department of Critical Care</addr-line>, <institution>University College London Hospital NHS Foundation Trust</institution>, <addr-line>3rd Floor, 235 Euston Road, London NW1 2BU</addr-line>, <country>UK</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Hardman</surname><given-names>J. G.</given-names></name><role>Handling editor</role></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. E-mail: <email>david.walker@uclh.nhs.uk</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>19</day><month>6</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>6</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>113</volume><issue>6</issue><fpage>910</fpage><lpage>921</lpage><permissions><copyright-statement>&#x000a9; The Author 2014. Published by Oxford University Press on behalf of the British Journal of Anaesthesia.</copyright-statement><copyright-year>2014</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="aeu157.pdf"/><abstract><p>The number of people travelling to malaria-endemic countries continues to increase, and malaria remains the commonest cause of serious imported infection in non-endemic areas. Severe malaria, mostly caused by <italic>Plasmodium falciparum</italic>, often requires intensive care unit (ICU) admission and can be complicated by cerebral malaria, respiratory distress, acute kidney injury, bleeding complications, and co-infection. The mortality from imported malaria remains significant. This article reviews the manifestations, complications and principles of management of severe malaria as relevant to critical care clinicians, incorporating recent studies of anti-malarial and adjunctive treatment. Effective management of severe malaria includes prompt diagnosis and early institution of effective anti-malarial therapy, recognition of complications, and appropriate supportive management in an ICU. All cases should be discussed with a specialist unit and transfer of the patient considered.</p></abstract><kwd-group><kwd>ARDS</kwd><kwd>ICU</kwd><kwd>imported infections</kwd><kwd>malaria</kwd></kwd-group></article-meta></front><body><boxed-text position="anchor"><caption><title>Editor's key points</title></caption><p>
<list list-type="bullet"><list-item><p>The authors describe the presentation and management of malaria on the ICU.</p></list-item><list-item><p>They review the literature and provide management strategies for dealing with this life-threatening condition.</p></list-item></list></p></boxed-text><p>The number of people who travel to malaria-endemic areas continues to increase (Fig.&#x000a0;<xref ref-type="fig" rid="AEU157F1">1</xref>).<sup><xref rid="AEU157C1" ref-type="bibr">1</xref></sup> Malaria is responsible for the death of at least three quarters of a million people worldwide every year<sup><xref rid="AEU157C2" ref-type="bibr">2</xref></sup> and is the commonest cause of serious imported infection in non-endemic areas.<sup><xref rid="AEU157C3" ref-type="bibr">3</xref>&#x02013;<xref rid="AEU157C5" ref-type="bibr">5</xref></sup> Severe malaria is mostly caused by <italic>Plasmodium falciparum</italic>, although other species can cause severe disease.<sup><xref rid="AEU157C6" ref-type="bibr">6</xref><xref rid="AEU157C7" ref-type="bibr">7</xref></sup>
<fig id="AEU157F1" position="float"><label>Fig&#x000a0;1</label><caption><p>Countries and areas with risk of malaria transmission. Map from WHO International Travel and Health Programme, <uri xlink:type="simple" xlink:href="http://www.who.int/ith/en/">http://www.who.int/ith/en/</uri>. Reproduced with permission of the World Health Organisation.</p></caption><graphic xlink:href="aeu15701"/></fig></p><p>Recommendations for the management of severe imported malaria are largely derived from trials in endemic regions and retrospective series of imported malaria. In spite of advances in management, the mortality rate of severe malaria remains &#x0223c;10% and data from the UK suggest that the outcome may be worse for patients managed in centres with less experience of treating the disease.<sup><xref rid="AEU157C8" ref-type="bibr">8</xref></sup> This review is based on recent studies of anti-malarial and supportive therapies and outlines the epidemiology of malaria, clinical manifestations, and risk stratification of severe disease, and provides an update on the management of patients with imported malaria requiring intensive care unit (ICU) support.</p><sec disp-level="2" id="s1a"><title>Epidemiology</title><p>Malaria is endemic throughout most of the tropics and sub-tropics and is one of the commonest causes of febrile illness in returning travellers.<sup><xref rid="AEU157C3" ref-type="bibr">3</xref>&#x02013;<xref rid="AEU157C5" ref-type="bibr">5</xref></sup> There were 6749 cases of imported malaria reported within the European Union in 2010 (0.99 cases per 100 000)<sup><xref rid="AEU157C9" ref-type="bibr">9</xref></sup> and 1688 cases reported in the USA (0.55 cases per 100 000).<sup><xref rid="AEU157C3" ref-type="bibr">3</xref></sup> In Europe, four countries (France, UK, Germany, and Italy) account for 80% of all cases. Surveillance from both Europe and the USA show that most cases of falciparum malaria are acquired in sub-Saharan Africa.<sup><xref rid="AEU157C3" ref-type="bibr">3</xref><xref rid="AEU157C10" ref-type="bibr">10</xref>&#x02013;<xref rid="AEU157C12" ref-type="bibr">12</xref></sup> Compared with malaria in endemic settings, where children are most commonly affected, imported malaria is predominantly a disease of young- and middle-aged adults&#x02014;the median age of cases in the UK is 31 years.<sup><xref rid="AEU157C13" ref-type="bibr">13</xref></sup></p><p>Surveillance data demonstrate that individuals originating from endemic regions who travel to &#x02018;visit friends and relatives&#x02019; are more likely to develop malaria than people who travel for other reasons (relative risk 3.65),<sup><xref rid="AEU157C5" ref-type="bibr">5</xref><xref rid="AEU157C13" ref-type="bibr">13</xref></sup> although these individuals may be at reduced risk of developing severe disease because of partial immunity.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref><xref rid="AEU157C14" ref-type="bibr">14</xref></sup> Anti-malarial chemoprophylaxis is very effective but surveillance data consistently demonstrate that most travellers do not take it appropriately.<sup><xref rid="AEU157C3" ref-type="bibr">3</xref><xref rid="AEU157C13" ref-type="bibr">13</xref><xref rid="AEU157C15" ref-type="bibr">15</xref></sup> Reasons for poor adherence include an assumption of low risk, particularly among individuals who grew up in endemic regions, and concerns about potential drug side effects.</p><p>Nearly all severe disease is caused by falciparum malaria; &#x0223c;10% of patients with imported falciparum malaria are reported to develop severe disease.<sup><xref rid="AEU157C3" ref-type="bibr">3</xref><xref rid="AEU157C16" ref-type="bibr">16</xref></sup> The case fatality rate is &#x0223c;1%.<sup><xref rid="AEU157C3" ref-type="bibr">3</xref><xref rid="AEU157C13" ref-type="bibr">13</xref></sup> UK surveillance data demonstrate significantly higher mortality (odds ratio 10.68) in patients aged &#x0003e;65 yr compared with adults aged 18&#x02013;35 yr and among tourists compared with patients originally from endemic countries (odds ratio 8.2).<sup><xref rid="AEU157C8" ref-type="bibr">8</xref></sup> Death from non-falciparum malaria is extremely rare with a case fatality rate of 0.05%.<sup><xref rid="AEU157C8" ref-type="bibr">8</xref></sup></p></sec><sec disp-level="2" id="s1b"><title>Pathophysiology</title><p>Malaria is caused by infection with the protozoan parasite <italic>Plasmodium</italic> and is transmitted by female Anopheline mosquitoes.<sup><xref rid="AEU157C17" ref-type="bibr">17</xref></sup> Four species are classically considered to cause disease in humans (<italic>P. falciparum</italic>, <italic>Plasmodium vivax</italic>, <italic>P. ovale</italic>, and <italic>P. malariae</italic>) although a fifth, <italic>P. knowlesi</italic>, is now recognized as a zoonotic cause of malaria in parts of Malaysia.<sup><xref rid="AEU157C18" ref-type="bibr">18</xref></sup> After the bite of an infected Anopheline mosquito (Fig.&#x000a0;<xref ref-type="fig" rid="AEU157F2">2</xref>), the inoculated sporozoites are taken up by hepatocytes where they mature over 7&#x02013;10 days to form schizonts. These then rupture to release variable numbers of merozoites into the blood. Merozoites rapidly invade erythrocytes, forming trophozoites, which again mature into schizonts over a period of 24&#x02013;72 h, depending on the species. The mature schizonts then rupture causing haemolysis, releasing further merozoites into the blood where they invade more erythrocytes. With <italic>P. falciparum</italic>, each schizont that ruptures releases 16 merozoites into the blood. Most schizonts adhere to the lining of small blood vessels in deep tissues, a process known as sequestration. The presence of schizonts in peripheral blood implies that the parasitaemia is likely to increase significantly and is itself a marker of severe disease. Human disease is caused by these asexual stages. Gametocytes, the sexual stage, develop some days later and it is these that are taken up by mosquitoes in endemic areas, where they breed and multiply in the mid-gut, ultimately leading to sprozoites found in the mosquitoes&#x02019; salivary glands. Gametocytes are frequently seen on blood films but, by themselves, are of no clinical significance.<sup><xref rid="AEU157C19" ref-type="bibr">19</xref></sup>
<fig id="AEU157F2" position="float"><label>Fig&#x000a0;2</label><caption><p>Life cycle of <italic>Plasmodium</italic>. Image from the Centers for Disease Control and Prevention (<uri xlink:type="simple" xlink:href="www.cdc.gov">www.cdc.gov</uri>). Image produced by CDC &#x02014; DPDx/Alexander J. da Silva, Melanie Moser.</p></caption><graphic xlink:href="aeu15702"/></fig></p><p>The incubation period for falciparum malaria is usually 12&#x02013;14 days and slightly longer for non-falciparum species. One series of imported malaria reported a median of 9.5 days (IQR 3&#x02013;14) between return from a malaria-endemic area and hospital admission.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref></sup> Progression to severe disease is variable; however, the largest series of severe imported malaria found a mean duration of symptoms of 5.5 days before ICU admission.<sup><xref rid="AEU157C20" ref-type="bibr">20</xref></sup></p><p>Infection with <italic>P. falciparum</italic> results in the expression of <italic>P. falciparum</italic> erythrocyte membrane protein 1 (<italic>Pf</italic>emp1), an important virulence factor, on the surface of red blood cells. <italic>Pf</italic>emp1 mediates binding of infected red blood cells to endothelial surfaces and sequestration in capillary beds.<sup><xref rid="AEU157C21" ref-type="bibr">21</xref></sup>
<italic>Pf</italic>emp1 is encoded by the <italic>var</italic> family of genes and the parasite regularly switches between &#x0223c;60 variants of this gene resulting in significant antigenic variation and an impaired immune response.<sup><xref rid="AEU157C21" ref-type="bibr">21</xref></sup> Release of pro-inflammatory cytokines, including TNF-&#x003b1; and IL-1, in response to infection leads to an up-regulation of endothelial receptors including Intracellular-Adhesion Molecule 1 resulting in further sequestration.<sup><xref rid="AEU157C22" ref-type="bibr">22</xref></sup> Occlusion of capillary beds leads to microvascular obstruction, tissue hypoperfusion, and lactic acidosis.<sup><xref rid="AEU157C23" ref-type="bibr">23</xref></sup> Capillary sequestration also impairs splenic clearance of infected red blood cells. The severity of disease is associated with both a higher total body parasite biomass and a higher biomass of sequestered parasites.<sup><xref rid="AEU157C24" ref-type="bibr">24</xref></sup></p></sec><sec disp-level="2" id="s1c"><title>Diagnosis</title><p>Microscopic examination of a blood film remains the gold standard for diagnosis of malaria (Fig.&#x000a0;<xref ref-type="fig" rid="AEU157F3">3</xref>).<sup><xref rid="AEU157C26" ref-type="bibr">26</xref></sup> This allows speciation, quantification of parasitaemia, and detection of other markers of severity such as the presence of schizonts. In a non-endemic setting, a parasite count &#x0003e;2% of infected red cells is usually considered a marker of severe disease although lower counts do not exclude this.<sup><xref rid="AEU157C26" ref-type="bibr">26</xref><xref rid="AEU157C27" ref-type="bibr">27</xref></sup> Both thick and thin films should be examined. Thick films have a higher sensitivity for diagnosis while thin films allow more accurate speciation and quantification of parasitaemia.<sup><xref rid="AEU157C28" ref-type="bibr">28</xref></sup> Rapid diagnostic tests (RDTs) are used in many settings. RDTs detect circulating parasite-associated proteins and enzymes. Most tests detect both a pan-species target and a falciparum-specific target. RDTs allow diagnosis of malaria without a trained microscopist but do not usually provide speciation nor quantification of parasitaemia. As such, these tests should be considered an adjunct rather than a replacement for blood film analysis.<sup><xref rid="AEU157C26" ref-type="bibr">26</xref><xref rid="AEU157C27" ref-type="bibr">27</xref></sup> The use of PCR to diagnose malaria remains a research tool, but may occasionally be useful, particularly when there is doubt about the infecting species, for example in the differentiation of <italic>P. knowlesii</italic> from <italic>P. malariae</italic>.
<fig id="AEU157F3" position="float"><label>Fig&#x000a0;3</label><caption><p>Health Protection Agency and British Infection Associated Algorithm for Initial Assessment and Management of Malaria in Adults.<sup><xref rid="AEU157C25" ref-type="bibr">25</xref></sup> &#x000a9; Crown copyright. Reproduced with permission of Public Health England.</p></caption><graphic xlink:href="aeu15703"/></fig></p></sec><sec disp-level="2" id="s1d"><title>Criteria for severe or complicated malaria</title><p>Criteria for severe malaria in both endemic and non-endemic settings have been defined by the World Health Organisation (WHO) (Table&#x000a0;<xref ref-type="table" rid="AEU157TB1">1</xref>).<sup><xref rid="AEU157C29" ref-type="bibr">29</xref></sup> In imported malaria, the commonest reasons for ICU admission are cerebral malaria, acute respiratory distress syndrome (ARDS), and acute kidney injury (AKI), either alone or in combination.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref><xref rid="AEU157C20" ref-type="bibr">20</xref><xref rid="AEU157C30" ref-type="bibr">30</xref></sup> As parasitized erythrocytes sequester in deep capillaries, the peripheral parasitaemia may not accurately reflect the true burden of infection. Hyperparasitaemia is therefore not a consistent finding in patients with severe malaria, and may not be a feature in a substantial proportion of patients requiring ICU admission.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref></sup>
<table-wrap id="AEU157TB1" position="float"><label>Table&#x000a0;1</label><caption><p>Criteria for severe malaria. Adapted from WHO Guidelines for the treatment of malaria, 2nd Edn.<sup><xref rid="AEU157C27" ref-type="bibr">27</xref></sup>
<uri xlink:type="simple" xlink:href="http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html">http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html</uri>. Reproduced with permission of the World Health Organisation</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/></colgroup><tbody><tr><td rowspan="1" colspan="1"><bold>Clinical features of severe falciparum infection</bold></td></tr><tr><td rowspan="1" colspan="1">&#x02003;Cerebral malaria as characterized by impaired consciousness or coma, convulsions, or both</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Acute respiratory distress syndrome</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Circulatory collapse</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Jaundice in the setting of other organ dysfunction</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Haemoglobinuria</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Abnormal spontaneous bleeding</td></tr><tr><td rowspan="1" colspan="1"><bold>Laboratory features of severe falciparum infection</bold></td></tr><tr><td rowspan="1" colspan="1">&#x02003;Hypoglycaemia [&#x0003c;2.2 mmol litre<sup>&#x02212;1</sup> (&#x0003c;40 mg dl<sup>&#x02212;1</sup>)]</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Severe anaemia (Hb &#x0003c;5 g dl<sup>&#x02212;1</sup>, packed cell volume &#x0003c;15%)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Metabolic acidosis (plasma bicarbonate &#x0003c;15 mmol litre<sup>&#x02212;1</sup> or pH &#x0003c;7.35)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Hyperparasitaemia (&#x0003e;2%/100 000 &#x000b5;l<sup>&#x02212;1</sup> in low-intensity transmission areas or &#x0003e;5% or 250 000 &#x000b5;l<sup>&#x02212;1</sup> in areas of high stable malaria transmission intensity)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Hyperlactataemia (lactate &#x0003e;5 mmol litre<sup>&#x02212;1</sup>)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Acute kidney injury (serum creatinine &#x0003e;265 &#x000b5;mol litre<sup>&#x02212;1</sup>).</td></tr></tbody></table></table-wrap></p></sec><sec id="s2"><title>Differential diagnosis</title><p>The differential diagnosis of severe malaria is broad and varies depending on the patient's travel history.<sup><xref rid="AEU157C31" ref-type="bibr">31</xref></sup> Major considerations include the common causes of community-acquired Gram-positive and Gram-negative bacterial sepsis, enteric fever, severe rickettsial infections, and leptospirosis, and also arboviral infections (including dengue fever) and the viral haemorrhagic fevers. Consultation with a specialist is recommended if there is any doubt as to the diagnoses or in any patient considered to be at risk of viral haemorrhagic fever.</p></sec><sec id="s3"><title>Anti-malarial drugs</title><p>Since the emergence of chloroquine resistance in the 1970s, parenteral quinine has been the mainstay of treatment for severe malaria (Table&#x000a0;<xref ref-type="table" rid="AEU157TB2">2</xref>). The commonest dose-related side effect of quinine is <italic>cinchonism</italic>, which comprises tinnitus, blurred vision, reversible hearing loss, headache, and nausea. Quinine may also cause hypoglycaemia and prolongation of the QTc interval on an electroencephalography (ECG) necessitating regular monitoring, but is usually well tolerated. Artemisinins, derived from the Chinese herb <italic>qinghausu</italic> or wormwood, have been used by Chinese traditional healers for many years but have become available to western practioners only in recent years.
<table-wrap id="AEU157TB2" position="float"><label>Table&#x000a0;2</label><caption><p>Anti-malarial therapy at the Hospital for Tropical Diseases. The Hospital for Tropical Diseases' treatment guidelines are based on part of the UK malaria treatment guidelines<sup><xref rid="AEU157C26" ref-type="bibr">26</xref></sup> but have been updated to reflect the growing importance of artesunate since the guidelines were published. *Quinine therapy should not be delayed if artesunate is not immediately available. Patients do not require treatment with both artesunate and quinine. Once the first dose of artesunate has been given, quinine can be stopped</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1"><bold>Route of administration</bold></th><th align="left" rowspan="1" colspan="1"><bold>Quinine</bold></th><th align="left" rowspan="1" colspan="1"><bold>Artesunate</bold>*</th></tr><tr><th align="left" rowspan="1" colspan="1"><bold>i.v.</bold></th><th align="left" rowspan="1" colspan="1"><bold>i.v.</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Dosing</td><td rowspan="1" colspan="1">20 mg kg<sup>&#x02212;1</sup> loading dose (max 1400 mg)<break/>Subsequently 10 mg kg<sup>&#x02212;1</sup> (max 700 mg) given 8 hourly</td><td rowspan="1" colspan="1">2.4 mg kg<sup>&#x02212;1</sup> at 0, 12, and 24 h and then once daily</td></tr><tr><td rowspan="1" colspan="1">Side effects</td><td rowspan="1" colspan="1">Cinchonism&#x02014;tinnitus, visual blurring, and nausea. Reversible and not an indication to stop quinine<break/>Hypoglycaemia<break/>Prolongation of the QT interval</td><td rowspan="1" colspan="1">Normally well tolerated although posttreatment haemolysis is recognized</td></tr><tr><td rowspan="1" colspan="1">Monitoring</td><td rowspan="1" colspan="1">Capillary blood sugar 2&#x02013;4 h<break/>ECG monitoring of QTc<break/>Continuous cardiac monitoring advised in patients with underlying cardiac disease</td><td rowspan="1" colspan="1">Not required</td></tr><tr><td rowspan="1" colspan="1">Follow-on therapy<break/>Therapy can be switched once the patient is improving clinically, the parasite count is &#x0003c;2%, and they can tolerate oral medication. Discuss with an expert</td><td rowspan="1" colspan="1">Oral quinine 10 mg kg<sup>&#x02212;1</sup> (max 700 mg) TDS to complete 7 days total course with either<break/>Doxycycline 200 mg for 1 week or<break/>Clindamycin 450 mg TDS for 1 week<break/>Doxycycline of clindamycin can be given either simultaneously (with both i.v./oral quinine) or after completion of quinine therapy</td><td rowspan="1" colspan="1">Artemether/Lumefantrine (Riamet, Co-Artem) four tablets at 0, 8, 24, 36, 48, and 60 h.<break/>Quinine (10 mg kg<sup>&#x02212;1</sup> max 700 mg) with doxycycline or clindamycin for a total of 7 days<break/>Atovaquone/Proguanil (Malarone) four tablets OD for 3 days</td></tr></tbody></table></table-wrap></p><p>The artemisinin derivative artesunate has recently been shown to be more effective than quinine for the treatment of severe falciparum malaria in two large randomized trials.<sup><xref rid="AEU157C32" ref-type="bibr">32</xref><xref rid="AEU157C33" ref-type="bibr">33</xref></sup> The SEAQUAMAT study randomized 1461 mostly adult patients with severe malaria in South and South-East Asia, and showed a significant reduction in mortality in patients treated with artesunate compared with quinine (15% <italic>vs</italic> 22%, <italic>P</italic>=0.0002).<sup><xref rid="AEU157C32" ref-type="bibr">32</xref></sup> The subsequent AQUAMAT study randomized 5425 children (&#x0003c;15 years) with severe malaria across eleven countries in sub-Saharan Africa and again showed a significant reduction in mortality with artesunate (8.5% <italic>vs</italic> 10.9% for quinine, <italic>P</italic>=0.0022).<sup><xref rid="AEU157C33" ref-type="bibr">33</xref></sup> Routine monitoring for hypoglycaemia and QT prolongation are unnecessary if an artemisinin derivative is used. Although extremely effective in treating malaria, they cannot be used as single agents as the rate of recrudescent infection is very high.</p><p>Availability of artesunate has been limited in many countries, including the UK, as the drug is not licenced and is only available on a named patient basis.<sup><xref rid="AEU157C34" ref-type="bibr">34</xref></sup> Because of this, parenteral artesunate is only available in relatively few specialist centres. Treatment with quinine should not be delayed while artesunate is obtained. If there is any doubt about the infecting species, then treatment for falciparum should be prescribed. Artemisinin combination treatments (ACTs), which combine an artemisinin with another effective anti-malarial drug, are now recommended by the WHO as first-line treatment for non-severe malaria<sup><xref rid="AEU157C27" ref-type="bibr">27</xref></sup> and should be used after initial treatment with parental artesunate. Early liaison with a specialist tropical medicine or infectious diseases unit is essential to ensure appropriate treatment as soon as possible. The treatment strategy used at the Hospital for Tropical Diseases, London, UK, is outlined in Table&#x000a0;<xref ref-type="table" rid="AEU157TB2">2</xref>.</p><p>Resistance to quinine has been widely reported from South-East Asia and occasionally from sub-Saharan Africa.<sup><xref rid="AEU157C35" ref-type="bibr">35</xref></sup> However, in the context of malaria, resistance is a relative rather than an absolute phenomenon. Partial artemisinin resistance has also been seen in South-East Asia, especially Cambodia, and Thailand<sup><xref rid="AEU157C36" ref-type="bibr">36</xref>&#x02013;<xref rid="AEU157C38" ref-type="bibr">38</xref></sup> and results in a decreased rate of clearance of asexual parasites from the blood. Treatment failure with ACTs has not yet been reported, but its development and the potential for artemisinin resistance spreading to Africa is a major concern.</p></sec><sec id="s4"><title>Exchange transfusion</title><p>Several anecdotal reports and some case series have supported the use of exchange transfusion in severe malaria, especially in patients with high parasitaemia; it continues to be recommended in some national guidelines.<sup><xref rid="AEU157C26" ref-type="bibr">26</xref></sup> The rationale is that exchange transfusion removes both infected red cells, lowering parasite burden and parasite-derived antigen load, and circulating pro-inflammatory cytokines. A recent report from a single-centre reported no deaths among 25 patients who had an exchange performed.<sup><xref rid="AEU157C39" ref-type="bibr">39</xref></sup> However, a meta-analysis in 2002 found only eight quasi-experimental studies of the efficacy of exchange transfusion and demonstrated no overall survival benefit, a finding echoed in a recent study of US patients;<sup><xref rid="AEU157C40" ref-type="bibr">40</xref></sup> the WHO states that no recommendation regarding exchange transfusion is possible based on the paucity of current evidence.<sup><xref rid="AEU157C27" ref-type="bibr">27</xref><xref rid="AEU157C41" ref-type="bibr">41</xref></sup> At our centre, exchange transfusion has not been used since the introduction of artemisinin-based therapy for all patients with severe malaria.</p></sec><sec id="s5"><title>Fluids and cardiac function</title><p>The traditional adage is that patients with severe malaria should be managed with relatively restricted fluid volumes because of concerns about the risk of capillary leak and lung and cerebral oedema. This practice is supported by the movement in critical care to a more fluid restrictive practice in patients with acute lung injury (ALI).<sup><xref rid="AEU157C42" ref-type="bibr">42</xref></sup> However, this restrictive fluid regimen commences only after initial resuscitation has been completed. No large trials have assessed fluid resuscitation strategies in patients with severe malaria in a developed world ICU setting; current data are derived only from trials in endemic areas and from small physiological studies.</p><p>The fluid expansion as supportive therapy study randomized 3141 African children presenting with severe febrile illness to maintenance fluids with or without boluses of either crystalloid (0.9% saline) or colloid (5% human albumin solution).<sup><xref rid="AEU157C43" ref-type="bibr">43</xref></sup> Malaria was the reason for admission in 57% of these children. The trial was stopped early because of a significant increase in mortality in both groups who received fluid boluses compared with the group receiving maintenance fluids only (4 week mortality 8.7% <italic>vs</italic> 12.0% and 12.2%, <italic>P</italic>=0.004 for comparison of maintenance with bolus). In a <italic>post hoc</italic> analysis, there was an increase in terminal cardiovascular events related to fluid resuscitation.<sup><xref rid="AEU157C44" ref-type="bibr">44</xref></sup> There were no differences in mortality between the sub-groups of children with malarial and bacterial infections. There are obvious limitations in applying these findings to critical care settings in the developed world as the children could not be offered mechanical ventilation, renal replacement therapy, nor inotropic support. Furthermore, time to hospital presentation, while not formally measured, was likely to be significantly longer than in a developed world setting, so the potential risk of an exaggerated reperfusion injury after aggressive resuscitation cannot be discounted.</p><p>Although not considered a traditional manifestation of severe malaria, there is emerging evidence that cardiac dysfunction may complicate severe disease. A number of studies have found evidence of increased circulating levels of cardiac enzymes including BNP in individuals with severe malaria.<sup><xref rid="AEU157C45" ref-type="bibr">45</xref>&#x02013;<xref rid="AEU157C47" ref-type="bibr">47</xref></sup> Intravascular haemolysis as a result of severe malaria has been shown in one small study to result in decreased levels of nitric oxide,<sup><xref rid="AEU157C47" ref-type="bibr">47</xref></sup> increased pulmonary pressures, and myocardial wall stress. Further studies to understand the clinical importance of cardiac dysfunction in severe malaria are warranted.</p><p>Previous studies have demonstrated that traditional markers of fluid balance correlate poorly with acid&#x02013;base status and respiratory function.<sup><xref rid="AEU157C48" ref-type="bibr">48</xref></sup> The argument against aggressive fluid loading is strengthened by recent data on the physiological response of 28 adult ICU patients with severe malaria to fluid expansion guided by invasive cardiac monitoring.<sup><xref rid="AEU157C23" ref-type="bibr">23</xref></sup> Despite trans-pulmonary thermodilution (PiCCO) guided therapy, acid&#x02013;base status deteriorated in 68% and no improvement in renal function was observed after volume expansion. Significant increases in extravascular lung water occurred in 17 of 22 (77%) patients who were liberally resuscitated, with eight developing frank pulmonary oedema despite being hypo- or euvolaemic. Five patients died, all of whom developed pulmonary oedema. The authors found that the degree of lactataemia correlated with the degree of parasite microvascular sequestration, but not with hypovolaemia.</p><p>It would appear that, in the absence of prospective, randomized trial data, liberal fluid therapy is best avoided in the context of severe malaria. Because of the propensity of these patients towards capillary leak and thus a greater risk of ARDS and cerebral oedema, our own management approach is to target significant hypovolaemia with concurrent tissue hypoperfusion, that is, clinical markers of organ dysfunction (e.g. oliguria) with biochemical markers (e.g. lactate and central venous oxygen saturation). Fluid loading is guided by a goal-directed algorithm using both the stroke volume response to a fluid challenge (measured by minimally invasive oesophageal Doppler) and markers of tissue perfusion as therapeutic endpoints. Otherwise, fluid balance is kept neutral, in line with studies in critically ill patients showing a strong association between positive fluid balance and worse outcomes.<sup><xref rid="AEU157C49" ref-type="bibr">49</xref></sup> Where vasopressor, inotrope, or both requirements persist, we maintain an acceptable cardiac output, avoiding fluid overload but targeting tissue perfusion and have a low threshold for diuresis in the haemodynamically stable patient in the postinflammatory phase of illness.</p></sec><sec id="s6"><title>Respiratory manifestations</title><p>The WHO defines respiratory manifestations of severe malaria in terms of deep breathing, respiratory distress, and pulmonary oedema.<sup><xref rid="AEU157C27" ref-type="bibr">27</xref></sup> Cough is a common symptom,<sup><xref rid="AEU157C50" ref-type="bibr">50</xref></sup> and tachypnoea may be caused by fever, anaemia, and a metabolic acidosis, and also primary lung pathology such as the ARDS and pneumonia. ARDS has clear diagnostic criteria that have been recently redefined,<sup><xref rid="AEU157C51" ref-type="bibr">51</xref></sup> with the previous clinical distinction between ALI and ARDS being replaced by mild, moderate, and severe levels of ARDS. This condition is more common among adults than children.<sup><xref rid="AEU157C52" ref-type="bibr">52</xref></sup> The reported incidence of &#x02018;respiratory distress&#x02019; in severe malaria varies between 2 and 30%, with differences in definitions accounting for some of this variation.<sup><xref rid="AEU157C10" ref-type="bibr">10</xref>&#x02013;<xref rid="AEU157C12" ref-type="bibr">12</xref><xref rid="AEU157C20" ref-type="bibr">20</xref><xref rid="AEU157C52" ref-type="bibr">52</xref>&#x02013;<xref rid="AEU157C54" ref-type="bibr">54</xref></sup> ARDS and respiratory distress are poor prognostic signs in both endemic and imported malaria.<sup><xref rid="AEU157C20" ref-type="bibr">20</xref><xref rid="AEU157C55" ref-type="bibr">55</xref><xref rid="AEU157C56" ref-type="bibr">56</xref></sup></p><p>The mechanisms underlying ARDS are not entirely understood, but likely causes include endothelial dysfunction and altered capillary permeability because of parasitized erythrocyte adherence and sequestration and exaggerated host immune and inflammatory responses, particularly TNF-&#x003b1;, IL-1, IL-6, and IL-8.<sup><xref rid="AEU157C57" ref-type="bibr">57</xref><xref rid="AEU157C58" ref-type="bibr">58</xref></sup> However, ARDS can develop after apparently successful treatment and after the disappearance of parasites from the blood.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref><xref rid="AEU157C53" ref-type="bibr">53</xref></sup> In these cases, ARDS may reflect persistence of inflammatory cytokines in the absence of any infected erythrocytes. There is emerging evidence that free parasite antigens may persist after treatment suggesting that these may represent a potential on-going stimuli for inflammation.<sup><xref rid="AEU157C52" ref-type="bibr">52</xref></sup> Concurrent bacterial pneumonia and cardiogenic pulmonary oedema (which may be iatrogenic, the result of renal failure, severe anaemia, or heart failure related to a sepsis-induced myocardial depression) are other important causes of respiratory distress.</p><p>As there are no specific trials addressing ARDS treatment in malaria, strategies are based on evidence-based ARDS management, including the use of low tidal volume &#x02018;protective&#x02019; ventilation and moderate levels of PEEP.<sup><xref rid="AEU157C59" ref-type="bibr">59</xref>&#x02013;<xref rid="AEU157C62" ref-type="bibr">62</xref></sup> Fluid balance is kept neutral, or negative if the patient is considered to be volume overloaded. Cerebral oedema and raised intracranial pressure associated with cerebral malaria may limit permissive hypercapnia and the use of high PEEP strategies; however, pragmatic clinical decision-making should be used.<sup><xref rid="AEU157C63" ref-type="bibr">63</xref></sup> Successful use of extracorporeal membrane oxygenation for severe respiratory failure has been reported in malaria.<sup><xref rid="AEU157C12" ref-type="bibr">12</xref><xref rid="AEU157C64" ref-type="bibr">64</xref></sup> Bacterial co-infection is relatively common suggesting that a low threshold for starting antibiotics, when supported by clinical and laboratory investigations, may be appropriate.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref><xref rid="AEU157C20" ref-type="bibr">20</xref><xref rid="AEU157C30" ref-type="bibr">30</xref></sup></p></sec><sec id="s7"><title>Hypoglycaemia</title><p>Hypoglycaemia, defined as blood glucose values &#x0003c;2.2 mmol litre<sup>&#x02212;1</sup> (&#x0003c;40 mg dl<sup>&#x02212;1</sup>),<sup><xref rid="AEU157C27" ref-type="bibr">27</xref></sup> is a common complication of malaria and can be a marker of severe disease, particularly in children.<sup><xref rid="AEU157C65" ref-type="bibr">65</xref><xref rid="AEU157C66" ref-type="bibr">66</xref></sup> Case series of imported malaria report a prevalence of hypoglycaemia between 1 and 20% at admission, with a higher rate among those who die.<sup><xref rid="AEU157C10" ref-type="bibr">10</xref>&#x02013;<xref rid="AEU157C12" ref-type="bibr">12</xref><xref rid="AEU157C20" ref-type="bibr">20</xref><xref rid="AEU157C54" ref-type="bibr">54</xref></sup> The pathogenesis is poorly understood but is thought to be related both to parasite glucose consumption and to impaired host gluconeogenesis rather than to malnutrition or hyper-insulinaemia.<sup><xref rid="AEU157C67" ref-type="bibr">67</xref></sup> Hypoglycaemia may be exacerbated by parenteral quinine (an insulin secretagogue). A meta-analysis reported a significantly lower incidence during treatment with artemisinins compared with quinine [combined HR 0.55 (95% CI 0.41&#x02013;0.74)].<sup><xref rid="AEU157C68" ref-type="bibr">68</xref></sup> Clinical features include a reduced level of consciousness and seizures. Blood glucose should be routinely and regularly assessed and monitored, especially during treatment with quinine. Early enteral feeding has been established as beneficial in a wide range of patients requiring intensive care, and may mitigate against hypoglycaemia in severe malaria.<sup><xref rid="AEU157C69" ref-type="bibr">69</xref><xref rid="AEU157C70" ref-type="bibr">70</xref></sup></p></sec><sec id="s8"><title>Neurological involvement</title><p>Cerebral malaria is strictly defined as coma [Glasgow Coma Score (GCS) &#x0003c;9] in a patient with malaria in whom other aetiologies have been excluded.<sup><xref rid="AEU157C29" ref-type="bibr">29</xref></sup> In clinical practice, a decrease in GCS &#x0003c;11 or the occurrence of seizures should be taken to represent cerebral malaria once hypoglycaemia and other potential causes of reduced consciousness have been excluded. As with respiratory distress, cerebral malaria is associated with worse outcomes.<sup><xref rid="AEU157C71" ref-type="bibr">71</xref></sup> The pathogenesis remains incompletely understood.<sup><xref rid="AEU157C72" ref-type="bibr">72</xref></sup> Electroencephalography has previously found sub-clinical seizure activity in a proportion of patients with cerebral malaria<sup><xref rid="AEU157C73" ref-type="bibr">73</xref></sup> which prompted three anti-epileptic trials.<sup><xref rid="AEU157C74" ref-type="bibr">74</xref>&#x02013;<xref rid="AEU157C76" ref-type="bibr">76</xref></sup> However, despite a reduction in seizure frequency, mortality was increased in patients receiving routine anti-convulsant therapy with phenobarbital.<sup><xref rid="AEU157C77" ref-type="bibr">77</xref></sup> This increased mortality is postulated to occur as a result of respiratory depression. The extent to which these findings can be generalized to other classes of anti-epileptics, in particular those that cause less respiratory depression, is unknown. In view of these findings, there is currently no role for routine EEG monitoring and the use of anti-epileptics in patients with cerebral malaria should be limited to those with clinically overt seizure activity.</p><p>Cerebral oedema is a well-recognized component of cerebral malaria and strategies to reduce this have been assessed in controlled trials. Warrell and colleagues<sup><xref rid="AEU157C78" ref-type="bibr">78</xref></sup> randomized patients with cerebral malaria to receive either dexamethasone or placebo. Mortality did not differ between the two groups (<italic>P</italic>=0.8) but coma was prolonged in those who received dexamethasone [63.2 (5.9) h <italic>vs</italic> 47.4 (3.2) h, <italic>P</italic>=0.02]. This finding is consistent with other studies of corticosteroids in cerebral oedema because of other aetiologies such as head injury.<sup><xref rid="AEU157C79" ref-type="bibr">79</xref></sup> Complications, including gastrointestinal bleeding and pneumonia, were also more common in patients receiving dexamethasone (<italic>P</italic>=0.004). Mohanty and colleagues<sup><xref rid="AEU157C80" ref-type="bibr">80</xref></sup> randomized 61 adult patients with cerebral malaria and CT-confirmed cerebral oedema to adjunctive treatment with mannitol. There was a non-significant trend towards a higher mortality in those receiving mannitol (30% <italic>vs</italic> 13%, HR 2.4 95% CI 0.8&#x02013;7.3, <italic>P</italic>=0.11). Mannitol was also associated with a significant increase in the duration of coma (90 h compared with 32 h with placebo, <italic>P</italic>=0.02). Other adjunctive treatments including N-acetyl cysteine, heparin, aspirin, deferoxamine, anti-TNF therapy, and pentoxifylline have all been trialled but none has been shown to be of benefit.<sup><xref rid="AEU157C81" ref-type="bibr">81</xref>&#x02013;<xref rid="AEU157C85" ref-type="bibr">85</xref></sup> No adjunctive treatments are currently recommended for cerebral malaria.</p></sec><sec id="s9"><title>Acute kidney injury</title><p>AKI in malaria is usually caused by <italic>P. falciparum</italic>, although it has been reported with other species.<sup><xref rid="AEU157C86" ref-type="bibr">86</xref><xref rid="AEU157C87" ref-type="bibr">87</xref></sup> The WHO uses a serum creatinine of &#x0003e;265 &#x000b5;mol litre<sup>&#x02212;1</sup> (or &#x02265;3 mg dl<sup>&#x02212;1</sup>) as a criterion for severe malaria,<sup><xref rid="AEU157C27" ref-type="bibr">27</xref></sup> although this definition is at variance with commonly applied definitions of AKI.<sup><xref rid="AEU157C88" ref-type="bibr">88</xref></sup> AKI is particularly common among individuals who did not grow up in endemic regions, suggesting that it may be more common in the malaria-na&#x000ef;ve.<sup><xref rid="AEU157C89" ref-type="bibr">89</xref>&#x02013;<xref rid="AEU157C91" ref-type="bibr">91</xref></sup> The incidence of AKI in severe malaria varies from 1 to 5% in endemic areas,<sup><xref rid="AEU157C91" ref-type="bibr">91</xref></sup> but the rate of AKI is much higher in series of imported malaria (ranging from 23 to &#x0003e;50%).<sup><xref rid="AEU157C10" ref-type="bibr">10</xref>&#x02013;<xref rid="AEU157C12" ref-type="bibr">12</xref><xref rid="AEU157C20" ref-type="bibr">20</xref><xref rid="AEU157C53" ref-type="bibr">53</xref><xref rid="AEU157C54" ref-type="bibr">54</xref></sup> Cytoadherence of parasitized erythrocytes to glomerular and tubular vascular beds, cytokine release, immune complex deposition, hypovolaemia, and haemolysis may all be contributory.<sup><xref rid="AEU157C57" ref-type="bibr">57</xref><xref rid="AEU157C91" ref-type="bibr">91</xref>&#x02013;<xref rid="AEU157C93" ref-type="bibr">93</xref></sup> Histopathological findings of AKI in severe malaria include acute tubular necrosis, interstitial nephritis, and glomerulonephritis, although tubular changes are the most common findings.<sup><xref rid="AEU157C89" ref-type="bibr">89</xref></sup></p><p>All patients with falciparum malaria should be screened for AKI, which may not develop until several days after the onset of fever and can be non-oliguric.<sup><xref rid="AEU157C91" ref-type="bibr">91</xref></sup> Management is supportive with maintenance of fluid balance and electrolytes and renal replacement therapy as indicated. Trials of both dopamine and epinephrine have been performed in severe malaria, but neither has been shown to improve renal oxygen metabolism nor function.<sup><xref rid="AEU157C94" ref-type="bibr">94</xref></sup> Artemisinin doses do not need adjusting in AKI; however, quinine may accumulate, so doses should be reduced by one-third after 48 h of established renal failure, unless renal replacement therapy has been initiated.<sup><xref rid="AEU157C27" ref-type="bibr">27</xref></sup> The prognosis of AKI associated with severe malaria is usually good, and it inevitably resolves in days to weeks. A recent UK series found that even those patients with persisting renal impairment at discharge from ICU ultimately recovered their renal function.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref></sup></p></sec><sec id="s10"><title>Co-infection</title><p>In endemic areas, concurrent community-acquired Gram-negative bacteraemia, in particular with non-typhoidal <italic>Salmonellae</italic>, has been shown to occur in 5&#x02013;12% of children with malaria.<sup><xref rid="AEU157C95" ref-type="bibr">95</xref>&#x02013;<xref rid="AEU157C97" ref-type="bibr">97</xref></sup> Recent studies have suggested that almost two-thirds of cases of community bacteraemia in endemic regions may be the result of malaria. Furthermore, invasive bacterial disease is associated with a worse prognosis.<sup><xref rid="AEU157C95" ref-type="bibr">95</xref>&#x02013;<xref rid="AEU157C97" ref-type="bibr">97</xref></sup> One proposed mechanism is induction of heme oxygenase-1, which mediates tolerance to malaria-induced haemolysis, resulting in reduced resistance to infection with non-typhoidal <italic>Salmonellae.</italic><sup><xref rid="AEU157C98" ref-type="bibr">98</xref></sup> However, few data are available on the frequency of bacteraemia in adult patients or returned travellers.</p><p>Rates of microbiologically confirmed community-acquired bacterial infections have been reported as 5&#x02013;10% in patients with imported malaria requiring ICU admission.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref><xref rid="AEU157C20" ref-type="bibr">20</xref><xref rid="AEU157C30" ref-type="bibr">30</xref></sup> Pneumonia was the commonest co-infection. Community-acquired bacteraemia has been reported in 1.5&#x02013;3% of cases requiring ICU admission. However, these studies were all retrospective and a failure to take blood cultures before antibiotics were administered may have resulted in an under-estimate of the true frequency of bacteraemia. The possibility of co-infection in returning travellers is an additional reason for early liaison with a specialist unit. High rates of co-infection with HIV have also been reported in some series.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref></sup></p><p>The use of empiric antibiotics remains controversial, but bacterial co-infection should be suspected in any patient with focal signs or symptoms of sepsis or significant neutrophilia. In such cases, blood cultures should be taken and broad-spectrum antibiotics commenced,<sup><xref rid="AEU157C27" ref-type="bibr">27</xref></sup> albeit de-escalating quickly or stopping treatment if bacterial infection is subsequently not confirmed. Clinicians should also remain alert to the possibility of nosocomial infection. Ventilator-associated pneumonia and catheter-related sepsis are well recognized in this setting and frequently contribute to poor outcomes despite adequate anti-malarial treatment.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref><xref rid="AEU157C20" ref-type="bibr">20</xref></sup></p></sec><sec id="s11"><title>Anaemia and coagulopathy</title><p>Malarial anaemia is caused by a combination of haemolysis, dyserythropoiesis, and removal of infected erythrocytes from the circulation by the spleen. Parasite antigens, antibody activation, and subtle alterations in red cell membranes may also result in a similar fate for uninfected cells.<sup><xref rid="AEU157C99" ref-type="bibr">99</xref></sup> WHO defines severe anaemia as a haemoglobin concentration of &#x0003c;5 g dl<sup>&#x02212;1</sup>.<sup><xref rid="AEU157C27" ref-type="bibr">27</xref></sup> However, severe malarial anaemia is mostly seen in endemic areas, especially among children and pregnant women, and is likely to be multifactorial.<sup><xref rid="AEU157C99" ref-type="bibr">99</xref></sup> Only one series of imported malaria reported patients presenting with severe anaemia as defined by the WHO.<sup><xref rid="AEU157C20" ref-type="bibr">20</xref></sup> Transfusion is recommended in severe anaemia, although no specific studies have addressed transfusion targets in malaria. Current critical care practice supports a restrictive use of red cell transfusions, and this is supported by WHO recommendations of a haemoglobin threshold of 7 g dl<sup>&#x02212;1</sup>, taking into account individual clinical circumstances.<sup><xref rid="AEU157C27" ref-type="bibr">27</xref><xref rid="AEU157C100" ref-type="bibr">100</xref><xref rid="AEU157C101" ref-type="bibr">101</xref></sup></p><p>Clinically apparent abnormal bleeding and coagulopathy is commonly seen in severe imported malaria, with a reported frequency ranging from &#x0003c;5%<sup><xref rid="AEU157C20" ref-type="bibr">20</xref><xref rid="AEU157C54" ref-type="bibr">54</xref><xref rid="AEU157C102" ref-type="bibr">102</xref><xref rid="AEU157C103" ref-type="bibr">103</xref></sup> to 20% or more.<sup><xref rid="AEU157C10" ref-type="bibr">10</xref>&#x02013;<xref rid="AEU157C12" ref-type="bibr">12</xref><xref rid="AEU157C53" ref-type="bibr">53</xref></sup> Profound thrombocytopenia is common in both severe and non-severe falciparum malaria and is probably caused by increased platelet consumption, sequestration within the spleen, or both. Disseminated intravascular coagulation, which occurs in about 5&#x02013;10% of severe imported malaria, should be treated conventionally with transfusion of screened blood products (whole blood, cryoprecipitate, fresh frozen plasma, and platelets) and guided by haematological expertise, but there is no evidence to support empirical platelet transfusion.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref><xref rid="AEU157C12" ref-type="bibr">12</xref><xref rid="AEU157C20" ref-type="bibr">20</xref></sup></p></sec><sec id="s12"><title>Prognosis</title><p>Mortality from severe malaria varies enormously by setting and clinical context. A mortality of &#x0003e;30% has been reported in children with respiratory distress and impaired consciousness.<sup><xref rid="AEU157C55" ref-type="bibr">55</xref></sup> In the UK, the overall case fatality rate from falciparum malaria is &#x0223c;1%.<sup><xref rid="AEU157C8" ref-type="bibr">8</xref></sup> Increased age and management at a centre with less experience of managing malaria have both been identified as risk factors for increased mortality, while individuals born in endemic countries had a lower mortality.<sup><xref rid="AEU157C8" ref-type="bibr">8</xref></sup> In studies of artemisinins, overall mortality was 10&#x02013;19%.<sup><xref rid="AEU157C32" ref-type="bibr">32</xref><xref rid="AEU157C33" ref-type="bibr">33</xref></sup> Case series of patients with imported malaria requiring ICU admission have reported mortality rates between 5 and 29%.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref><xref rid="AEU157C104" ref-type="bibr">104</xref></sup> Older age, reduced GCS, and higher parasitaemia at ICU admission were significantly associated with an increased mortality in the largest cohort,<sup><xref rid="AEU157C20" ref-type="bibr">20</xref></sup> albeit not consistently replicated in other studies.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref><xref rid="AEU157C30" ref-type="bibr">30</xref></sup></p></sec><sec id="s13"><title>Risk stratification</title><p>Two scoring systems have been proposed for the stratification of adult patients with severe malaria.<sup><xref rid="AEU157C105" ref-type="bibr">105</xref><xref rid="AEU157C106" ref-type="bibr">106</xref></sup> Hanson and colleagues<sup><xref rid="AEU157C105" ref-type="bibr">105</xref></sup> derived a simple score (coma&#x02013;acidosis&#x02013;malaria score) using arterial base deficit and GCS derived from SEAQUAMAT trial data.<sup><xref rid="AEU157C32" ref-type="bibr">32</xref></sup> Patients score 0&#x02013;2 points for their GCS level and 0&#x02013;2 points for base deficit. A total score of &#x0003c;2 accurately identified patients who survived (positive predictive value 95.8%). However, the positive predictive value of CAM scores for mortality is more limited.</p><p>Mishra and colleagues<sup><xref rid="AEU157C106" ref-type="bibr">106</xref></sup> derived the malaria score for adults (MSA) based on the presence or absence of severe anaemia (1 point), AKI (2 points), respiratory distress (3 points), and cerebral malaria (4 points). Mortality increased steadily with an increasing MSA, from 2% for MSA scores of 0&#x02013;2 to 90% for those scoring &#x02265;7. Taking MSA scores of 5 as a cut-off, they reported a sensitivity of 89.9% for mortality and a positive predictive value of 94.1%. As with the CAM score, patients with imported malaria having a low score (&#x0003c;5) had good predictive power for survival, whereas high scores had a limited predictive power for death.<sup><xref rid="AEU157C11" ref-type="bibr">11</xref></sup> The utility of both these scores is likely to vary significantly between resource-rich and resource-scarce settings.</p></sec><sec sec-type="conclusions" id="s14"><title>Conclusions</title><p>Rates of international travel continue to increase and the &#x02018;febrile returned traveller&#x02019; is an increasingly common clinical problem. Malaria remains the most important cause of imported fever and cases requiring ICU admission continue to be associated with a high mortality. While there have been significant advances in our understanding of the management of malaria in the last decade, high-quality data to guide management of imported malaria remain scarce, with most derived from endemic settings or retrospective series. The emergence of artemisinin-based therapy has translated into a significant improvement in outcomes in endemic countries and is likely to improve outcomes in imported malaria in the future. Despite numerous studies, no adjunctive therapy has been shown yet to confer a survival advantage and several have proved harmful. ICU management remains supportive and improved outcomes may be attributable more to advances in multi-disciplinary team working, mechanical ventilation strategies, careful fluid management, and infection control. Despite these advances, the mortality from imported malaria remains significant; all cases should be discussed with a specialist unit and transfer of the patient considered.</p></sec><sec id="s15"><title>Authors&#x02019; contributions</title><p>M.M. and A.G.-W. wrote the first and subsequent drafts of the paper. M.S. reviewed and redrafted the paper. J.F.D. and D.W. conceived of the article, reviewed, and redrafted the paper.</p></sec><sec id="s16"><title>Declaration of interest</title><p>The authors declare that they have no relevant conflicts of interest.</p></sec><sec id="s17"><title>Funding</title><p>This study was supported by the Special Trustees of the Hospital for Tropical Diseases. All the authors are supported by the UCLH/UCL Biomedical Research Centre Infection, Immunity and Inflammation Theme. Michael Marks is a <funding-source id="cs1" rid="cn1">Wellcome Trust Clinical Research Fellow</funding-source> (<award-id id="cn1" rid="cs1">WT102807</award-id>) at the London School of Hygiene and Tropical Medicine. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></sec></body><back><ref-list><title>References</title><ref id="AEU157C1"><label>1</label><element-citation publication-type="confproc"><collab>United Nations World Tourism Organization (UNWTO)</collab><source>UNWTO Tourism Highlights</source><edition>2012 Edn.</edition><conf-date>2012</conf-date><publisher-loc>Madrid, Spain UNWTO</publisher-loc></element-citation></ref><ref id="AEU157C2"><label>2</label><element-citation publication-type="book"><collab>World Health Organization</collab><article-title>World Malaria Report 2012</article-title><year>2012</year><publisher-loc>Geneva</publisher-loc><publisher-name>WHO</publisher-name></element-citation></ref><ref id="AEU157C3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mali</surname><given-names>S</given-names></name><name><surname>Kachur</surname><given-names>SP</given-names></name><name><surname>Arguin</surname><given-names>PM</given-names></name></person-group><article-title>Malaria surveillance&#x02014;United States, 2009</article-title><source>MMWR Surveill Summ</source><year>2012</year><volume>61</volume><fpage>1</fpage><pub-id pub-id-type="pmid">22377962</pub-id></element-citation></ref><ref id="AEU157C4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odolini</surname><given-names>S</given-names></name><name><surname>Parola</surname><given-names>P</given-names></name><name><surname>Gkrania-Klotsas</surname><given-names>E</given-names></name><etal/></person-group><article-title>Travel-related imported infections in Europe, EuroTravNet 2009</article-title><source>Clin Microbiol Infect</source><year>2012</year><volume>18</volume><fpage>468</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">21848975</pub-id></element-citation></ref><ref id="AEU157C5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leder</surname><given-names>K</given-names></name><name><surname>Torresi</surname><given-names>J</given-names></name><name><surname>Libman</surname><given-names>MD</given-names></name><etal/></person-group><article-title>GeoSentinel surveillance of illness in returned travelers, 2007&#x02013;2011</article-title><source>Ann Intern Med</source><year>2013</year><volume>158</volume><fpage>456</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">23552375</pub-id></element-citation></ref><ref id="AEU157C6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baird</surname><given-names>JK</given-names></name></person-group><article-title>Severe and fatal vivax malaria challenges &#x02018;benign tertian malaria&#x02019; dogma</article-title><source>Ann Trop Paediatr</source><year>2009</year><volume>29</volume><fpage>251</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">19941746</pub-id></element-citation></ref><ref id="AEU157C7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox-Singh</surname><given-names>J</given-names></name><name><surname>Hiu</surname><given-names>J</given-names></name><name><surname>Lucas</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Severe malaria&#x02014;a case of fatal <italic>Plasmodium knowlesi</italic> infection with post-mortem findings: a case report</article-title><source>Malar J</source><year>2010</year><volume>9</volume><fpage>10</fpage><pub-id pub-id-type="pmid">20064229</pub-id></element-citation></ref><ref id="AEU157C8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Checkley</surname><given-names>AM</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>V</given-names></name><etal/></person-group><article-title>Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study</article-title><source>Br Med J</source><year>2012</year><volume>344</volume><fpage>e2116</fpage><pub-id pub-id-type="pmid">22454091</pub-id></element-citation></ref><ref id="AEU157C9"><label>9</label><element-citation publication-type="book"><collab>European Centre for Disease Prevention and Control</collab><article-title>Annual Epidemiological Report 2012: Reporting on 2010 Surveillance Data and 2011 Epidemic Intelligence Data</article-title><publisher-loc>Stockholm</publisher-loc><comment>Available from <uri xlink:type="simple" xlink:href="http://www.ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&#x00026;ID=753&#x00026;RootFolder=%2Fen%2Fpublications%2FPublications&#x00026;Web=270275b7-419a-4352-a8fb-f0c757d92e66">http://www.ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&#x00026;ID=753&#x00026;RootFolder=%2Fen%2Fpublications%2FPublications&#x00026;Web=270275b7-419a-4352-a8fb-f0c757d92e66</uri></comment></element-citation></ref><ref id="AEU157C10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>A</given-names></name><name><surname>Nicol&#x000e1;s</surname><given-names>JM</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Severe imported malaria in adults: retrospective study of 20 cases</article-title><source>Am J Trop Med Hyg</source><year>2009</year><volume>81</volume><fpage>595</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19815872</pub-id></element-citation></ref><ref id="AEU157C11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname><given-names>ME</given-names></name><name><surname>Armstrong</surname><given-names>M</given-names></name><name><surname>Suvari</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Severe imported falciparum malaria among adults requiring intensive care: a retrospective study at the hospital for tropical diseases, London</article-title><source>BMC Infect Dis</source><year>2013</year><volume>13</volume><fpage>118</fpage><pub-id pub-id-type="pmid">23497139</pub-id></element-citation></ref><ref id="AEU157C12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>LC</given-names></name><name><surname>Abreu</surname><given-names>CF</given-names></name><name><surname>Xerinda</surname><given-names>SM</given-names></name><name><surname>Tavares</surname><given-names>M</given-names></name><name><surname>Lucas</surname><given-names>R</given-names></name><name><surname>Sarmento</surname><given-names>AC</given-names></name></person-group><article-title>Severe imported malaria in an intensive care unit: a review of 59 cases</article-title><source>Malar J</source><year>2012</year><volume>11</volume><fpage>96</fpage><pub-id pub-id-type="pmid">22458840</pub-id></element-citation></ref><ref id="AEU157C13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>AD</given-names></name><name><surname>Bradley</surname><given-names>DJ</given-names></name><name><surname>Smith</surname><given-names>V</given-names></name><etal/></person-group><article-title>Imported malaria and high risk groups: observational study using UK surveillance data 1987&#x02013;2006</article-title><source>Br Med J</source><year>2008</year><volume>337</volume><fpage>a120</fpage><lpage>a120</lpage><pub-id pub-id-type="pmid">18599471</pub-id></element-citation></ref><ref id="AEU157C14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>A</given-names></name><name><surname>Bassett</surname><given-names>P</given-names></name><name><surname>Zeki</surname><given-names>S</given-names></name><name><surname>Newman</surname><given-names>S</given-names></name><name><surname>Pasvol</surname><given-names>G</given-names></name></person-group><article-title>Risk factors for severe disease in adults with falciparum malaria</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><fpage>871</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">19243243</pub-id></element-citation></ref><ref id="AEU157C15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ericsson</surname><given-names>CD</given-names></name><name><surname>Hatz</surname><given-names>C</given-names></name><name><surname>Leder</surname><given-names>K</given-names></name><etal/></person-group><article-title>Illness in travelers visiting friends and relatives: a review of the GeoSentinel surveillance network</article-title><source>Clin Infect Dis</source><year>2006</year><volume>43</volume><fpage>1185</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">17029140</pub-id></element-citation></ref><ref id="AEU157C16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kain</surname><given-names>KC</given-names></name><name><surname>Harrington</surname><given-names>MA</given-names></name><name><surname>Tennyson</surname><given-names>S</given-names></name><name><surname>Keystone</surname><given-names>JS</given-names></name></person-group><article-title>Imported malaria: prospective analysis of problems in diagnosis and management</article-title><source>Clin Infect Dis</source><year>1998</year><volume>27</volume><fpage>142</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9675468</pub-id></element-citation></ref><ref id="AEU157C17"><label>17</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Warrell</surname><given-names>D</given-names></name><name><surname>Gilles</surname><given-names>H</given-names></name></person-group><source>Essential Malariology</source><year>2002</year><edition>4th Edn</edition><publisher-name>London: Hodder Arnold</publisher-name></element-citation></ref><ref id="AEU157C18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daneshvar</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>TME</given-names></name><name><surname>Cox-Singh</surname><given-names>J</given-names></name><etal/></person-group><article-title>Clinical and laboratory features of human <italic>Plasmodium knowlesi</italic> infection</article-title><source>Clin Infect Dis</source><year>2009</year><volume>49</volume><fpage>852</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">19635025</pub-id></element-citation></ref><ref id="AEU157C19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>C</given-names></name><name><surname>Armstrong</surname><given-names>M</given-names></name><name><surname>Zatyka</surname><given-names>E</given-names></name></person-group><article-title>Gametocyte carriage in <italic>Plasmodium falciparum</italic>-infected travellers</article-title><source>Malar J</source><year>2013</year><volume>12</volume><fpage>31</fpage><pub-id pub-id-type="pmid">23347669</pub-id></element-citation></ref><ref id="AEU157C20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruneel</surname><given-names>F</given-names></name><name><surname>Tubach</surname><given-names>F</given-names></name><name><surname>Corne</surname><given-names>P</given-names></name><etal/></person-group><article-title>Severe imported falciparum malaria: a cohort study in 400 critically ill adults</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><fpage>e13236</fpage><pub-id pub-id-type="pmid">20949045</pub-id></element-citation></ref><ref id="AEU157C21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flick</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name></person-group><article-title>var genes, <italic>Pf</italic>EMP1 and the human host</article-title><source>Mol Biochem Parasit</source><year>2004</year><volume>134</volume><fpage>3</fpage><lpage>9</lpage></element-citation></ref><ref id="AEU157C22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berendt</surname><given-names>AR</given-names></name><name><surname>Simmons</surname><given-names>DL</given-names></name><name><surname>Tansey</surname><given-names>J</given-names></name><name><surname>Newbold</surname><given-names>CI</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name></person-group><article-title>Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for <italic>Plasmodium falciparum</italic></article-title><source>Nature</source><year>1989</year><volume>341</volume><fpage>57</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2475784</pub-id></element-citation></ref><ref id="AEU157C23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>JP</given-names></name><name><surname>Lam</surname><given-names>SWK</given-names></name><name><surname>Mohanty</surname><given-names>S</given-names></name><etal/></person-group><article-title>Fluid resuscitation of adults with severe falciparum malaria: effects on acid&#x02013;base status, renal function, and extravascular lung water</article-title><source>Crit Care Med</source><year>2013</year><volume>41</volume><fpage>972</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">23324951</pub-id></element-citation></ref><ref id="AEU157C24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dondorp</surname><given-names>AM</given-names></name><name><surname>Desakorn</surname><given-names>V</given-names></name><name><surname>Pongtavornpinyo</surname><given-names>W</given-names></name><etal/></person-group><article-title>Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2</article-title><source>PLoS Med</source><year>2005</year><volume>2</volume><fpage>e204</fpage><pub-id pub-id-type="pmid">16104831</pub-id></element-citation></ref><ref id="AEU157C25"><label>25</label><element-citation publication-type="other"><collab>Health Protection Agency</collab><article-title>Malaria&#x02014;Algorithm for Initial Assessment and Management in Adults</article-title><comment>Available from <uri xlink:type="simple" xlink:href="http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1240212774627">http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1240212774627</uri> (accessed September 2013)</comment></element-citation></ref><ref id="AEU157C26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalloo</surname><given-names>DG</given-names></name><name><surname>Shingadia</surname><given-names>D</given-names></name><name><surname>Pasvol</surname><given-names>G</given-names></name><etal/></person-group><article-title>UK malaria treatment guidelines</article-title><source>J Infect</source><year>2007</year><volume>54</volume><fpage>111</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">17215045</pub-id></element-citation></ref><ref id="AEU157C27"><label>27</label><element-citation publication-type="book"><collab>World Health Organization</collab><source>Guidelines for the Treatment of Malaria</source><year>2011</year><edition>2nd Edn.</edition><publisher-loc>Geneva</publisher-loc></element-citation></ref><ref id="AEU157C28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>D</given-names></name></person-group><article-title>Use and limitations of light microscopy for diagnosing malaria at the primary health care level</article-title><source>Bull World Health Organ</source><year>1988</year><volume>66</volume><fpage>621</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2463112</pub-id></element-citation></ref><ref id="AEU157C29"><label>29</label><element-citation publication-type="journal"><collab>World Health Organization</collab><article-title>Severe falciparum malaria</article-title><source>Trans R Soc Trop Med Hyg</source><year>2000</year><volume>94</volume><issue>Suppl.</issue><fpage>1</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">10748883</pub-id></element-citation></ref><ref id="AEU157C30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruneel</surname><given-names>F</given-names></name><name><surname>Hocqueloux</surname><given-names>L</given-names></name><name><surname>Alberti</surname><given-names>C</given-names></name><etal/></person-group><article-title>The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>167</volume><fpage>684</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12411286</pub-id></element-citation></ref><ref id="AEU157C31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>V</given-names></name><name><surname>Stockley</surname><given-names>JM</given-names></name><name><surname>Dockrell</surname><given-names>D</given-names></name><etal/></person-group><article-title>Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management</article-title><source>J Infection</source><year>2009</year><volume>59</volume><fpage>1</fpage><lpage>18</lpage></element-citation></ref><ref id="AEU157C32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dondorp</surname><given-names>A</given-names></name><name><surname>Nosten</surname><given-names>F</given-names></name><name><surname>Stepniewska</surname><given-names>K</given-names></name><name><surname>Day</surname><given-names>N</given-names></name><name><surname>White</surname><given-names>N</given-names></name></person-group><article-title>South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group</article-title><source>Lancet</source><year>2005</year><volume>366</volume><fpage>717</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">16125588</pub-id></element-citation></ref><ref id="AEU157C33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dondorp</surname><given-names>AM</given-names></name><name><surname>Fanello</surname><given-names>CI</given-names></name><name><surname>Hendriksen</surname><given-names>ICE</given-names></name><etal/></person-group><article-title>Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial</article-title><source>Lancet</source><year>2010</year><volume>376</volume><fpage>1647</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">21062666</pub-id></element-citation></ref><ref id="AEU157C34"><label>34</label><element-citation publication-type="journal"><collab>DTB</collab><article-title>Artemisinins in malaria treatment in the UK</article-title><source>Drug Ther Bull</source><year>2010</year><volume>48</volume><fpage>129</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">21057033</pub-id></element-citation></ref><ref id="AEU157C35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>JT</given-names></name><name><surname>Juliano</surname><given-names>JJ</given-names></name><name><surname>Wongsrichanalai</surname><given-names>C</given-names></name></person-group><article-title>Drug-resistant malaria: the era of ACT</article-title><source>Curr Infect Dis Rep</source><year>2010</year><volume>12</volume><fpage>165</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">21308525</pub-id></element-citation></ref><ref id="AEU157C36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amaratunga</surname><given-names>C</given-names></name><name><surname>Sreng</surname><given-names>S</given-names></name><name><surname>Suon</surname><given-names>S</given-names></name><etal/></person-group><article-title>Artemisinin-resistant <italic>Plasmodium falciparum</italic> in Pursat province, western Cambodia: a parasite clearance rate study</article-title><source>Lancet Infect Dis</source><year>2012</year><volume>12</volume><fpage>851</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22940027</pub-id></element-citation></ref><ref id="AEU157C37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phyo</surname><given-names>AP</given-names></name><name><surname>Nkhoma</surname><given-names>S</given-names></name><name><surname>Stepniewska</surname><given-names>K</given-names></name><etal/></person-group><article-title>Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study</article-title><source>Lancet</source><year>2012</year><volume>379</volume><fpage>1960</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">22484134</pub-id></element-citation></ref><ref id="AEU157C38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dondorp</surname><given-names>AM</given-names></name><name><surname>Nosten</surname><given-names>F</given-names></name><name><surname>Yi</surname><given-names>P</given-names></name><etal/></person-group><article-title>Artemisinin resistance in <italic>Plasmodium falciparum</italic> malaria</article-title><source>New Engl J Med</source><year>2009</year><volume>361</volume><fpage>455</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">19641202</pub-id></element-citation></ref><ref id="AEU157C39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Genderen</surname><given-names>PJ</given-names></name><name><surname>Hesselink</surname><given-names>DA</given-names></name><name><surname>Bezemer</surname><given-names>JM</given-names></name><name><surname>Wismans</surname><given-names>PJ</given-names></name><name><surname>Overbosch</surname><given-names>D</given-names></name></person-group><article-title>Efficacy and safety of exchange transfusion as an adjunct therapy for severe <italic>Plasmodium falciparum</italic> malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol</article-title><source>Transfusion</source><year>2010</year><volume>50</volume><fpage>787</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">19951317</pub-id></element-citation></ref><ref id="AEU157C40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>KR</given-names></name><name><surname>Wiegand</surname><given-names>RE</given-names></name><name><surname>Arguin</surname><given-names>PM</given-names></name></person-group><article-title>Exchange transfusion for severe malaria: evidence base and literature review</article-title><source>Clin Infect Dis</source><year>2013</year><volume>57</volume><fpage>923</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23800940</pub-id></element-citation></ref><ref id="AEU157C41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riddle</surname><given-names>MS</given-names></name><name><surname>Jackson</surname><given-names>JL</given-names></name><name><surname>Sanders</surname><given-names>JW</given-names></name><name><surname>Blazes</surname><given-names>DL</given-names></name></person-group><article-title>Exchange transfusion as an adjunct therapy in severe <italic>Plasmodium falciparum</italic> malaria: a meta-analysis</article-title><source>Clin Infect Dis</source><year>2002</year><volume>34</volume><fpage>1192</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11941545</pub-id></element-citation></ref><ref id="AEU157C42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiedemann</surname><given-names>HP</given-names></name><name><surname>Wheeler</surname><given-names>AP</given-names></name><name><surname>Bernard</surname><given-names>GR</given-names></name><etal/></person-group><article-title>Comparison of two fluid-management strategies in acute lung injury</article-title><source>New Engl J Med</source><year>2006</year><volume>354</volume><fpage>2564</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">16714767</pub-id></element-citation></ref><ref id="AEU157C43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maitland</surname><given-names>K</given-names></name><name><surname>Kiguli</surname><given-names>S</given-names></name><name><surname>Opoka</surname><given-names>RO</given-names></name><etal/></person-group><article-title>Mortality after fluid bolus in African children with severe infection</article-title><source>New Engl J Med</source><year>2011</year><volume>364</volume><fpage>2483</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">21615299</pub-id></element-citation></ref><ref id="AEU157C44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maitland</surname><given-names>K</given-names></name><name><surname>George</surname><given-names>EC</given-names></name><name><surname>Evans</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial</article-title><source>BMC Med</source><year>2013</year><volume>11</volume><fpage>68</fpage><pub-id pub-id-type="pmid">23496872</pub-id></element-citation></ref><ref id="AEU157C45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrhardt</surname><given-names>S</given-names></name><name><surname>Wichmann</surname><given-names>D</given-names></name><name><surname>Hemmer</surname><given-names>CJ</given-names></name><name><surname>Burchard</surname><given-names>GD</given-names></name><name><surname>Brattig</surname><given-names>NW</given-names></name></person-group><article-title>Circulating concentrations of cardiac proteins in complicated and uncomplicated <italic>Plasmodium falciparum</italic> malaria</article-title><source>Trop Med Int Health</source><year>2004</year><volume>9</volume><fpage>1099</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">15482402</pub-id></element-citation></ref><ref id="AEU157C46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herr</surname><given-names>J</given-names></name><name><surname>Mehrfar</surname><given-names>P</given-names></name><name><surname>Schmiedel</surname><given-names>S</given-names></name><etal/></person-group><article-title>Reduced cardiac output in imported <italic>Plasmodium falciparum</italic> malaria</article-title><source>Malar J</source><year>2011</year><volume>10</volume><fpage>160</fpage><pub-id pub-id-type="pmid">21658247</pub-id></element-citation></ref><ref id="AEU157C47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janka</surname><given-names>JJ</given-names></name><name><surname>Koita</surname><given-names>OA</given-names></name><name><surname>Traore</surname><given-names>B</given-names></name><etal/></person-group><article-title>Increased pulmonary pressures and myocardial wall stress in children with severe malaria</article-title><source>J Infect Dis</source><year>2010</year><volume>202</volume><fpage>791</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">20662718</pub-id></element-citation></ref><ref id="AEU157C48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>HP</given-names></name><name><surname>Hanson</surname><given-names>J</given-names></name><name><surname>Bethell</surname><given-names>D</given-names></name><etal/></person-group><article-title>A retrospective analysis of the haemodynamic and metabolic effects of fluid resuscitation in Vietnamese adults with severe falciparum malaria</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e25523</fpage><pub-id pub-id-type="pmid">22022406</pub-id></element-citation></ref><ref id="AEU157C49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>JH</given-names></name><name><surname>Forbes</surname><given-names>J</given-names></name><name><surname>Nakada</surname><given-names>T</given-names></name><name><surname>Walley</surname><given-names>KR</given-names></name><name><surname>Russell</surname><given-names>JA</given-names></name></person-group><article-title>Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality</article-title><source>Crit Care Med</source><year>2011</year><volume>39</volume><fpage>259</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">20975548</pub-id></element-citation></ref><ref id="AEU157C50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anstey</surname><given-names>NM</given-names></name><name><surname>Jacups</surname><given-names>SP</given-names></name><name><surname>Cain</surname><given-names>T</given-names></name><etal/></person-group><article-title>Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity</article-title><source>J Infect Dis</source><year>2002</year><volume>185</volume><fpage>1326</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12001051</pub-id></element-citation></ref><ref id="AEU157C51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>ND</given-names></name><name><surname>Fan</surname><given-names>E</given-names></name><name><surname>Camporota</surname><given-names>L</given-names></name><etal/></person-group><article-title>The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material</article-title><source>Intensive Care Med</source><year>2012</year><volume>38</volume><fpage>1573</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">22926653</pub-id></element-citation></ref><ref id="AEU157C52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>WRJ</given-names></name><name><surname>Hanson</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>GDH</given-names></name><name><surname>White</surname><given-names>NJ</given-names></name><name><surname>Dondorp</surname><given-names>AM</given-names></name></person-group><article-title>Respiratory manifestations of malaria</article-title><source>Chest</source><year>2012</year><volume>142</volume><fpage>492</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">22871759</pub-id></element-citation></ref><ref id="AEU157C53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badiaga</surname><given-names>S</given-names></name><name><surname>Brouqui</surname><given-names>P</given-names></name><name><surname>Carpentier</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Severe imported malaria: clinical presentation at the time of hospital admission and outcome in 42 cases diagnosed from 1996 to 2002</article-title><source>J Emerg Med</source><year>2005</year><volume>29</volume><fpage>375</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">16243192</pub-id></element-citation></ref><ref id="AEU157C54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>S</given-names></name><name><surname>Mohanty</surname><given-names>NK</given-names></name><name><surname>Rath</surname><given-names>J</given-names></name><name><surname>Patnaik</surname><given-names>SB</given-names></name></person-group><article-title>Spectrum of malaria complications in an intensive care unit</article-title><source>Singapore Med J</source><year>2010</year><volume>51</volume><fpage>226</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20428736</pub-id></element-citation></ref><ref id="AEU157C55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Forster</surname><given-names>D</given-names></name><name><surname>Waruiru</surname><given-names>C</given-names></name><etal/></person-group><article-title>Indicators of life-threatening malaria in African children</article-title><source>New Engl J Med</source><year>1995</year><volume>332</volume><fpage>1399</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">7723795</pub-id></element-citation></ref><ref id="AEU157C56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>T</given-names></name><name><surname>Mosha</surname><given-names>F</given-names></name><name><surname>Grainge</surname><given-names>M</given-names></name><name><surname>Madeley</surname><given-names>R</given-names></name></person-group><article-title>Indicators of mortality in African adults with malaria</article-title><source>T Roy Soc Trop Med H</source><year>2006</year><volume>100</volume><fpage>719</fpage><lpage>24</lpage></element-citation></ref><ref id="AEU157C57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>NP</given-names></name><name><surname>Hien</surname><given-names>TT</given-names></name><name><surname>Schollaardt</surname><given-names>T</given-names></name><etal/></person-group><article-title>The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria</article-title><source>J Infect Dis</source><year>1999</year><volume>180</volume><fpage>1288</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">10479160</pub-id></element-citation></ref><ref id="AEU157C58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>SK</given-names></name><name><surname>Bollineni</surname><given-names>S</given-names></name></person-group><article-title>Acute lung injury and acute respiratory distress syndrome in malaria</article-title><source>J Vect Borne Dis</source><year>2008</year><volume>45</volume><fpage>179</fpage><lpage>93</lpage></element-citation></ref><ref id="AEU157C59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briel</surname><given-names>M</given-names></name><name><surname>Meade</surname><given-names>M</given-names></name><name><surname>Mercat</surname><given-names>A</given-names></name><etal/></person-group><article-title>Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis</article-title><source>J Am Med Assoc</source><year>2010</year><volume>303</volume><fpage>865</fpage><lpage>73</lpage></element-citation></ref><ref id="AEU157C60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamontagne</surname><given-names>F</given-names></name><name><surname>Briel</surname><given-names>M</given-names></name><name><surname>Guyatt</surname><given-names>GH</given-names></name><name><surname>Cook</surname><given-names>DJ</given-names></name><name><surname>Bhatnagar</surname><given-names>N</given-names></name><name><surname>Meade</surname><given-names>M</given-names></name></person-group><article-title>Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials</article-title><source>J Crit Care</source><year>2010</year><volume>25</volume><fpage>420</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">19896324</pub-id></element-citation></ref><ref id="AEU157C61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Putensen</surname><given-names>C</given-names></name><name><surname>Theuerkauf</surname><given-names>N</given-names></name><name><surname>Zinserling</surname><given-names>J</given-names></name><name><surname>Wrigge</surname><given-names>H</given-names></name><name><surname>Pelosi</surname><given-names>P</given-names></name></person-group><article-title>Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury</article-title><source>Ann Intern Med</source><year>2009</year><volume>151</volume><fpage>566</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">19841457</pub-id></element-citation></ref><ref id="AEU157C62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellinger</surname><given-names>RP</given-names></name><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Rhodes</surname><given-names>A</given-names></name><etal/></person-group><article-title>Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012</article-title><source>Intensive Care Med</source><year>2013</year><volume>39</volume><fpage>165</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">23361625</pub-id></element-citation></ref><ref id="AEU157C63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponsford</surname><given-names>MJ</given-names></name><name><surname>Medana</surname><given-names>IM</given-names></name><name><surname>Prapansilp</surname><given-names>P</given-names></name><etal/></person-group><article-title>Sequestration and microvascular congestion are associated with coma in human cerebral malaria</article-title><source>J Infect Dis</source><year>2012</year><volume>205</volume><fpage>663</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">22207648</pub-id></element-citation></ref><ref id="AEU157C64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandroux</surname><given-names>D</given-names></name><name><surname>Leaute</surname><given-names>B</given-names></name><name><surname>Hoarau</surname><given-names>N</given-names></name><etal/></person-group><article-title>High frequency oscillation ventilation and extracorporeal membrane oxygenation during pernicious malaria</article-title><source>Med Mal Infect</source><year>2011</year><volume>41</volume><fpage>209</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">21194862</pub-id></element-citation></ref><ref id="AEU157C65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willcox</surname><given-names>ML</given-names></name><name><surname>Forster</surname><given-names>M</given-names></name><name><surname>Dicko</surname><given-names>MI</given-names></name><name><surname>Graz</surname><given-names>B</given-names></name><name><surname>Mayon-White</surname><given-names>R</given-names></name><name><surname>Barennes</surname><given-names>H</given-names></name></person-group><article-title>Blood glucose and prognosis in children with presumed severe malaria: is there a threshold for &#x02018;hypoglycaemia&#x02019;?</article-title><source>Trop Med Int Health</source><year>2010</year><volume>15</volume><fpage>232</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">19961563</pub-id></element-citation></ref><ref id="AEU157C66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jallow</surname><given-names>M</given-names></name><name><surname>Casals-Pascual</surname><given-names>C</given-names></name><name><surname>Ackerman</surname><given-names>H</given-names></name><etal/></person-group><article-title>Clinical features of severe malaria associated with death: a 13-year observational study in the Gambia</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e45645</fpage><pub-id pub-id-type="pmid">23029157</pub-id></element-citation></ref><ref id="AEU157C67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>TE</given-names></name><name><surname>Molyneux</surname><given-names>ME</given-names></name><name><surname>Wirima</surname><given-names>JJ</given-names></name><name><surname>Fletcher</surname><given-names>KA</given-names></name><name><surname>Morris</surname><given-names>K</given-names></name></person-group><article-title>Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria</article-title><source>New Engl J Med</source><year>1988</year><volume>319</volume><fpage>1040</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3050516</pub-id></element-citation></ref><ref id="AEU157C68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>D</given-names></name><name><surname>Donegan</surname><given-names>S</given-names></name><name><surname>Isba</surname><given-names>R</given-names></name><name><surname>Lalloo</surname><given-names>DG</given-names></name></person-group><article-title>Artesunate versus quinine for treating severe malaria</article-title><source>Cochrane Database Syst Rev</source><year>2012</year><volume>6</volume><fpage>CD005967</fpage><pub-id pub-id-type="pmid">22696354</pub-id></element-citation></ref><ref id="AEU157C69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martindale</surname><given-names>RG</given-names></name><name><surname>McClave</surname><given-names>SA</given-names></name><name><surname>Vanek</surname><given-names>VW</given-names></name><etal/></person-group><article-title>Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary</article-title><source>Crit Care Med</source><year>2009</year><volume>37</volume><fpage>1757</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">19373044</pub-id></element-citation></ref><ref id="AEU157C70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maude</surname><given-names>RJ</given-names></name><name><surname>Hoque</surname><given-names>G</given-names></name><name><surname>Hasan</surname><given-names>MU</given-names></name><etal/></person-group><article-title>Timing of enteral feeding in cerebral malaria in resource-poor settings: a randomized trial</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e27273</fpage><pub-id pub-id-type="pmid">22110624</pub-id></element-citation></ref><ref id="AEU157C71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaffar</surname><given-names>S</given-names></name><name><surname>Van Hensbroek</surname><given-names>MB</given-names></name><name><surname>Palmer</surname><given-names>A</given-names></name><name><surname>Schneider</surname><given-names>G</given-names></name><name><surname>Greenwood</surname><given-names>B</given-names></name></person-group><article-title>Predictors of a fatal outcome following childhood cerebral malaria</article-title><source>Am J Trop Med Hyg</source><year>1997</year><volume>57</volume><fpage>20</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9242312</pub-id></element-citation></ref><ref id="AEU157C72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>NH</given-names></name><name><surname>Golenser</surname><given-names>J</given-names></name><name><surname>Chan-Ling</surname><given-names>T</given-names></name><etal/></person-group><article-title>Immunopathogenesis of cerebral malaria</article-title><source>Int J Parasitol</source><year>2006</year><volume>36</volume><fpage>569</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">16678181</pub-id></element-citation></ref><ref id="AEU157C73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawley</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Muthinji</surname><given-names>P</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Kirkham</surname><given-names>F</given-names></name></person-group><article-title>Electroencephalographic and clinical features of cerebral malaria</article-title><source>Arch Dis Child</source><year>2001</year><volume>84</volume><fpage>247</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">11207176</pub-id></element-citation></ref><ref id="AEU157C74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawley</surname><given-names>J</given-names></name><name><surname>Waruiru</surname><given-names>C</given-names></name><name><surname>Mithwani</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study</article-title><source>Lancet</source><year>2000</year><volume>355</volume><fpage>701</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10703801</pub-id></element-citation></ref><ref id="AEU157C75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochar</surname><given-names>D</given-names></name><name><surname>Kumawat</surname><given-names>B</given-names></name><name><surname>Bajya</surname><given-names>H</given-names></name><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Kochar</surname><given-names>S</given-names></name><name><surname>Agarwal</surname><given-names>R</given-names></name></person-group><article-title>Prophylactic role of single dose phenobarbitone in preventing convulsions in cerebral malaria</article-title><source>J Assoc Physicians India</source><year>1997</year><volume>45</volume><fpage>123</fpage><lpage>4</lpage></element-citation></ref><ref id="AEU157C76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>NJ</given-names></name><name><surname>Looareesuwan</surname><given-names>S</given-names></name><name><surname>Phillips</surname><given-names>RE</given-names></name><name><surname>Chanthavanich</surname><given-names>P</given-names></name><name><surname>Warrell</surname><given-names>DA</given-names></name></person-group><article-title>Single dose phenobarbitone prevents convulsions in cerebral malaria</article-title><source>Lancet</source><year>1988</year><volume>2</volume><fpage>64</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2898696</pub-id></element-citation></ref><ref id="AEU157C77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meremikwu</surname><given-names>M</given-names></name><name><surname>Marson</surname><given-names>AG</given-names></name></person-group><article-title>Routine anticonvulsants for treating cerebral malaria</article-title><source>Cochrane Database Syst Rev</source><year>2002</year><issue>2</issue><fpage>CD002152</fpage><pub-id pub-id-type="pmid">12076440</pub-id></element-citation></ref><ref id="AEU157C78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warrell</surname><given-names>DA</given-names></name><name><surname>Looareesuwan</surname><given-names>S</given-names></name><name><surname>Warrell</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients</article-title><source>New Engl J Med</source><year>1982</year><volume>306</volume><fpage>313</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7033788</pub-id></element-citation></ref><ref id="AEU157C79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>I</given-names></name><name><surname>Yates</surname><given-names>D</given-names></name><name><surname>Sandercock</surname><given-names>P</given-names></name><etal/></person-group><article-title>Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial</article-title><source>Lancet</source><year>2004</year><volume>364</volume><fpage>1321</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15474134</pub-id></element-citation></ref><ref id="AEU157C80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohanty</surname><given-names>S</given-names></name><name><surname>Mishra</surname><given-names>SK</given-names></name><name><surname>Patnaik</surname><given-names>R</given-names></name><etal/></person-group><article-title>Brain swelling and mannitol therapy in adult cerebral malaria: a randomized trial</article-title><source>Clin Infect Dis</source><year>2011</year><volume>53</volume><fpage>349</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">21810747</pub-id></element-citation></ref><ref id="AEU157C81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charunwatthana</surname><given-names>P</given-names></name><name><surname>Faiz</surname><given-names>MA</given-names></name><name><surname>Ruangveerayut</surname><given-names>R</given-names></name><etal/></person-group><article-title>N-acetylcysteine as adjunctive treatment in severe malaria: A randomized, double-blinded placebo-controlled clinical trial</article-title><source>Crit Care Med</source><year>2009</year><volume>37</volume><fpage>516</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">19114891</pub-id></element-citation></ref><ref id="AEU157C82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemmer</surname><given-names>CJ</given-names></name><name><surname>Kern</surname><given-names>P</given-names></name><name><surname>Holst</surname><given-names>FG</given-names></name><name><surname>Nawroth</surname><given-names>PP</given-names></name><name><surname>Dietrich</surname><given-names>M</given-names></name></person-group><article-title>Neither heparin nor acetylsalicylic acid influence the clinical course in human <italic>Plasmodium falciparum</italic> malaria: a prospective randomized study</article-title><source>Am J Trop Med Hyg</source><year>1991</year><volume>45</volume><fpage>608</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">1951871</pub-id></element-citation></ref><ref id="AEU157C83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordeuk</surname><given-names>V</given-names></name><name><surname>Thuma</surname><given-names>P</given-names></name><name><surname>Brittenham</surname><given-names>G</given-names></name><etal/></person-group><article-title>Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria</article-title><source>New Engl J Med</source><year>1992</year><volume>327</volume><fpage>1473</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1406879</pub-id></element-citation></ref><ref id="AEU157C84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Hensbroek</surname><given-names>MB</given-names></name><name><surname>Palmer</surname><given-names>A</given-names></name><name><surname>Onyiorah</surname><given-names>E</given-names></name><etal/></person-group><article-title>The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria</article-title><source>J Infect Dis</source><year>1996</year><volume>174</volume><fpage>1091</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8896514</pub-id></element-citation></ref><ref id="AEU157C85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Looareesuwan</surname><given-names>S</given-names></name><name><surname>Wilairatana</surname><given-names>P</given-names></name><name><surname>Vannaphan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand</article-title><source>Am J Trop Med Hyg</source><year>1998</year><volume>58</volume><fpage>348</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">9546417</pub-id></element-citation></ref><ref id="AEU157C86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>BS</given-names></name></person-group><article-title>Renal failure in malaria</article-title><source>J Vect Bor Dis</source><year>2008</year><volume>45</volume><fpage>83</fpage><lpage>97</lpage></element-citation></ref><ref id="AEU157C87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Kumar</surname><given-names>NS</given-names></name><name><surname>Saxena</surname><given-names>RK</given-names></name></person-group><article-title>Acute renal failure in Plasmodium vivax malaria</article-title><source>J Assoc Physicians India</source><year>2003</year><volume>51</volume><fpage>265</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12839348</pub-id></element-citation></ref><ref id="AEU157C88"><label>88</label><element-citation publication-type="journal"><article-title>KDIGO clinical practice guideline for acute kidney injury</article-title><source>Kidney Int Suppl</source><year>2012</year><volume>2</volume><fpage>19</fpage><lpage>36</lpage></element-citation></ref><ref id="AEU157C89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barsoum</surname><given-names>RS</given-names></name></person-group><article-title>Malarial acute renal failure</article-title><source>J Am Soc Nephrol</source><year>2000</year><volume>11</volume><fpage>2147</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">11053494</pub-id></element-citation></ref><ref id="AEU157C90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eiam-Ong</surname><given-names>S</given-names></name></person-group><article-title>Malarial nephropathy</article-title><source>Semin Nephrol</source><year>2003</year><volume>23</volume><fpage>21</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">12563598</pub-id></element-citation></ref><ref id="AEU157C91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>SK</given-names></name><name><surname>Das</surname><given-names>BS</given-names></name></person-group><article-title>Malaria and acute kidney injury</article-title><source>Semin Nephrol</source><year>2008</year><volume>28</volume><fpage>395</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">18620962</pub-id></element-citation></ref><ref id="AEU157C92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacPherson</surname><given-names>GG</given-names></name><name><surname>Warrell</surname><given-names>MJ</given-names></name><name><surname>White</surname><given-names>NJ</given-names></name><name><surname>Looareesuwan</surname><given-names>S</given-names></name><name><surname>Warrell</surname><given-names>DA</given-names></name></person-group><article-title>Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration</article-title><source>Am J Pathol</source><year>1985</year><volume>119</volume><fpage>385</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">3893148</pub-id></element-citation></ref><ref id="AEU157C93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguansangiam</surname><given-names>S</given-names></name><name><surname>Day</surname><given-names>NPJ</given-names></name><name><surname>Hien</surname><given-names>TT</given-names></name><etal/></person-group><article-title>A quantitative ultrastructural study of renal pathology in fatal <italic>Plasmodium falciparum</italic> malaria</article-title><source>Trop Med Int Health</source><year>2007</year><volume>12</volume><fpage>1037</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">17875015</pub-id></element-citation></ref><ref id="AEU157C94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>NP</given-names></name><name><surname>Phu</surname><given-names>NH</given-names></name><name><surname>Mai</surname><given-names>NT</given-names></name><etal/></person-group><article-title>Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis</article-title><source>Crit Care Med</source><year>2000</year><volume>28</volume><fpage>1353</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">10834678</pub-id></element-citation></ref><ref id="AEU157C95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadjm</surname><given-names>B</given-names></name><name><surname>Amos</surname><given-names>B</given-names></name><name><surname>Mtove</surname><given-names>G</given-names></name><etal/></person-group><article-title>WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense <italic>Plasmodium falciparum</italic> transmission: prospective study</article-title><source>Br Med J</source><year>2010</year><volume>340</volume><fpage>c1350</fpage><pub-id pub-id-type="pmid">20354024</pub-id></element-citation></ref><ref id="AEU157C96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkley</surname><given-names>J</given-names></name><name><surname>Mwarumba</surname><given-names>S</given-names></name><name><surname>Bramham</surname><given-names>K</given-names></name><name><surname>Lowe</surname><given-names>B</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name></person-group><article-title>Bacteraemia complicating severe malaria in children</article-title><source>T Roy Soc Trop Med H</source><year>1999</year><volume>93</volume><fpage>283</fpage><lpage>6</lpage></element-citation></ref><ref id="AEU157C97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>JAG</given-names></name><name><surname>Berkley</surname><given-names>JA</given-names></name><name><surname>Mwangi</surname><given-names>I</given-names></name><etal/></person-group><article-title>Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case&#x02013;control study and a longitudinal study</article-title><source>Lancet</source><year>2011</year><volume>378</volume><fpage>1316</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">21903251</pub-id></element-citation></ref><ref id="AEU157C98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunnington</surname><given-names>AJ</given-names></name><name><surname>de Souza</surname><given-names>JB</given-names></name><name><surname>Walther</surname><given-names>R-M</given-names></name><name><surname>Riley</surname><given-names>EM</given-names></name></person-group><article-title>Malaria impairs resistance to <italic>Salmonella</italic> through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization</article-title><source>Nat Med</source><year>2011</year><volume>18</volume><fpage>120</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22179318</pub-id></element-citation></ref><ref id="AEU157C99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haldar</surname><given-names>K</given-names></name><name><surname>Mohandas</surname><given-names>N</given-names></name></person-group><article-title>Malaria, erythrocytic infection, and anemia</article-title><source>Hematology Am Soc Hematol Educ Program</source><year>2009</year><volume>1</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">20008186</pub-id></element-citation></ref><ref id="AEU157C100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000e9;bert</surname><given-names>PC</given-names></name><name><surname>Wells</surname><given-names>G</given-names></name><name><surname>Blajchman</surname><given-names>MA</given-names></name><etal/></person-group><article-title>A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group</article-title><source>New Engl J Med</source><year>1999</year><volume>340</volume><fpage>409</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">9971864</pub-id></element-citation></ref><ref id="AEU157C101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>JL</given-names></name><name><surname>Terrin</surname><given-names>ML</given-names></name><name><surname>Noveck</surname><given-names>H</given-names></name><etal/></person-group><article-title>Liberal or restrictive transfusion in high-risk patients after hip surgery</article-title><source>New Engl J Med</source><year>2011</year><volume>365</volume><fpage>2453</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">22168590</pub-id></element-citation></ref><ref id="AEU157C102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thierfelder</surname><given-names>C</given-names></name><name><surname>Schill</surname><given-names>C</given-names></name><name><surname>Hatz</surname><given-names>C</given-names></name><name><surname>N&#x000fc;esch</surname><given-names>R</given-names></name></person-group><article-title>Trends in imported malaria to Basel, Switzerland</article-title><source>J Travel Med</source><year>2008</year><volume>15</volume><fpage>432</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">19090798</pub-id></element-citation></ref><ref id="AEU157C103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwake</surname><given-names>L</given-names></name><name><surname>Streit</surname><given-names>JP</given-names></name><name><surname>Edler</surname><given-names>L</given-names></name><name><surname>Encke</surname><given-names>J</given-names></name><name><surname>Stremmel</surname><given-names>W</given-names></name><name><surname>Junghanss</surname><given-names>T</given-names></name></person-group><article-title>Early treatment of imported falciparum malaria in the intermediate and intensive care unit setting: an 8-year single-center retrospective study</article-title><source>Crit Care</source><year>2008</year><volume>12</volume><fpage>R22</fpage><pub-id pub-id-type="pmid">18294371</pub-id></element-citation></ref><ref id="AEU157C104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumberg</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>RP</given-names></name><name><surname>Lipman</surname><given-names>J</given-names></name><name><surname>Beards</surname><given-names>S</given-names></name></person-group><article-title>Predictors of mortality in severe malaria: a two year experience in a non-endemic area</article-title><source>Anaesthesia Intensive Care</source><year>1996</year><volume>24</volume><fpage>217</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">9133196</pub-id></element-citation></ref><ref id="AEU157C105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Mohanty</surname><given-names>S</given-names></name><etal/></person-group><article-title>A simple score to predict the outcome of severe malaria in adults</article-title><source>Clin Infect Dis</source><year>2010</year><volume>50</volume><fpage>679</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">20105074</pub-id></element-citation></ref><ref id="AEU157C106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>SK</given-names></name><name><surname>Panigrahi</surname><given-names>P</given-names></name><name><surname>Mishra</surname><given-names>R</given-names></name><name><surname>Mohanty</surname><given-names>S</given-names></name></person-group><article-title>Prediction of outcome in adults with severe falciparum malaria: a new scoring system</article-title><source>Malar J</source><year>2007</year><volume>6</volume><fpage>24</fpage><pub-id pub-id-type="pmid">17326839</pub-id></element-citation></ref></ref-list></back></article>